跳至主要内容
临床试验/NCT02606955
NCT02606955Unknown不适用

Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?

Miulli General Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Assessment of the gold standard method for the measurement of DW (in kg) through the comparison of clinical DW (as determined by means of a validated clinical score) and BIA DW (measurement of the resistance in kilohertz).

研究概览

简要总结

Clinical methods are fundamental in probing the DW. They must be supported by strict BIA protocols. REST appears to be a (the) brilliant solution in solving the old problem of DW in HD patients

详细描述

Probing the dry weight (DW) was largely dependent on clinical subjective estimates until recently. New bedside non-invasive tools have been developed with the aim of providing more objective information on volume status and guiding physicians in the quest for DW. Among them, bioimpedance (BIA) appears to be very promising.

Very recently, a BIA test aimed at assessing DW in hemodialysis (HD) patients has been developed, the "REsistance Stabilization Test" (REST). It is called BIA DW. Its rationale is based on the achievement of the flattening of the curve of the ratio R0/Rt (R0 is resistance at time 0 and Rt is resistance at a given time t during the HD session) of less than + 1% over 20 minutes in the presence of ongoing ultrafiltration.

Study protocol: the Clinical DW is the gold standard by definition. It is determined under strict clinical surveillance by the same attending physician. She/he will be helped by a clinical score of volume state about symptoms and signs of hypo- or hypervolemia. Then, this Clinical DW will be compared with BIA DW, as obtained after performing REST

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • stable uremic patients
  • thrice weekly hemodialysis treatment
  • start of hemodialysis treatment since at least 3 months

排除标准

  • overt edema
  • liver cirrhosis
  • cardiac failure
  • serum albumin < 3g/dl
  • pregnancy
  • metallic implants or a pacemaker
  • limb amputation

结局指标

主要结局

Assessment of the gold standard method for the measurement of DW (in kg) through the comparison of clinical DW (as determined by means of a validated clinical score) and BIA DW (measurement of the resistance in kilohertz).

时间窗: up to 4 weeks

次要结局

未报告次要终点

研究者

发起方
Miulli General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlo Basile, M.D.

Scientific Director of the Division of Nephrology

Miulli General Hospital

研究点 (2)

Loading locations...

相似试验

Probing the Dry Weight by Bioimpedance: The... | 临床试验